DUNS:
# of Employees: N/A
HUBZone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
The goal of the research is to develop a potent, pharmacologically useful inhibitor of farnesyltransferase for use as a new therapeutic agent for cancer. The Ras family of oncogenes and proto-oncogene ...
The goal of the research is to develop a potent pharmacologically useful inhibitor of the CD45 protein tyrosine phosphatase. CD45 is a transmembrane protein having a highly glycosylated extracellular ...
THE GOAL OF THE RESEARCH IS TO DEVELOP A POTENT PHARMACOLOGICALLY USEFUL INHIBITOR OF GLYCOSPHINGOLIPID (GSL) BIOSYNTHESIS. GSLS PLAY IMPORTANT ROLES IN (1) CANCER CELL METASTASIS, PROLIFERATION, AND ...
THE GOAL OF THIS RESEARCH IS TO DEVELOP A POTENT AND SPECIFIC PHARMACOLOGICALLY USEFUL ANTAGONIST TO THE LEUKOTRIENE B4 (LTB4) RECEPTOR FOR USE AS A NEW THERAPEUTIC AGENT IN MYOCARDIAL INFARCTION. LTB ...
THE GOAL OF THE PROPOSED RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR PLATELET ACTIVATING FACTOR (PAF). PAF IS A LIPID MEDIATOR PRODUCED BY A VARIETY OF INFLAMMATORY CEL ...
THE GOAL OF THIS RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR LEUKOTRIENE E4 AND LEUKOTRIENE E4-N-ACETATE, TWO IMPORTANT METABOLITES OF LEUKOTRIENE C4 AND D4. THESE LEUK ...